Lepu Medical to inject USD12.5 mln into American company Rgenix

Xinhua Financein
2018-10-11 09:32

Already collect

Lepu Medical Technology (Beijing) Co., Ltd. announced that it plans to invest 12.5 million U.S. dollars to join in series C funding of American biopharmaceutical company Rgenix.

According to a company filing, it would like to introduce first in-class drugs, including RGX-104 into China, conducting clinical trials and market development in the country.

The introduction of Rgenix's products not only complements the company's product line of cancer immunotherapy, but also forms a combination of tumor immunotherapy products with its own characteristics, enhancing the company's core competitiveness in tumor immunotherapy. 
Add comments

Latest comments

Latest News
News Most Viewed